Literature DB >> 15547110

Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress.

Agostino Virdis1, Rocchina Colucci, Matteo Fornai, Corrado Blandizzi, Emiliano Duranti, Stefania Pinto, Nunzia Bernardini, Cristina Segnani, Luca Antonioli, Stefano Taddei, Antonio Salvetti, Mario Del Tacca.   

Abstract

We investigated whether cyclooxygenase (COX) isoforms (COX-1 and COX-2) and decreased NO availability contribute to endothelial dysfunction in endotoxemic rats. The involvement of reactive oxygen species (ROS) was also evaluated. Rats were injected with Salmonella-derived lipopolysaccharide or saline. After 6 h, endothelial function of mesenteric resistance arteries was evaluated. In controls, acetylcholine (ACh)-induced relaxation was inhibited by the nitric-oxide synthase inhibitor N(G)-monomethyl-l-arginine (l-NMMA) and unaffected by 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)-phenyl-2(5H)-furanone (DFU) (COX-2 inhibitor). In lipopolysaccharide (LPS)-treated rats, the response to ACh was blunted compared with controls, less sensitive to l-NMMA, and enhanced by DFU. COX-2 blockade also improved the inhibitory effect of l-NMMA on cholinergic relaxation. SC-560 [5-(4-clorophenyl)-1-(4-metoxyphenyl)-3-trifluoromethylpirazole] (COX-1 inhibitor) did not modify the response to ACh in both groups. LPS-induced endothelial dysfunction was unaffected by the thromboxane A(2) (TxA(2)) receptor antagonist SQ-29548 (7-[3-[[2-[(phenylamino)carbonyl]hydrazino]methyl]-7-oxabicyclo[2.2.1] hept-2-yl]-[1S(1alpha,2alpha(Z),3alpha,4alpha)]-5-heptenoic acid). In vivo inducible nitric-oxide synthase (iNOS) inhibition by S-methylisothiourea partly attenuated LPS-induced endothelial dysfunction. The antioxidants ascorbic acid and superoxide dismutase normalized endothelium-dependent relaxation and restored the inhibitory action of l-NMMA on ACh. Responses to sodium nitroprusside were similar in both groups. In LPS-treated rats, reverse transcription-polymerase chain reaction showed a marked increase in mesenteric iNOS and COX-2 expressions, whereas endothelial nitric-oxide synthase and COX-1 were unchanged. LPS-induced COX-2 overexpression was reduced but not abrogated by S-methylisothiourea. LPS-induced COX-2 up-regulation was also documented by immunohistochemistry. In conclusion, mesenteric resistance vessels from endotoxemic rats show impaired endothelial function due to reduced NO availability, a condition that is partly ascribable to an iNOS-dependent enhanced COX-2 expression, whereas TxA(2) does not seem to be involved. Oxidative stress is the main mechanism responsible for reduced NO availability, and COX-2 might act as a source of ROS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15547110     DOI: 10.1124/jpet.104.077644

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  20 in total

1.  Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD(P)H oxidase and COX-1.

Authors:  Rocchina Colucci; Matteo Fornai; Emiliano Duranti; Luca Antonioli; Ilaria Rugani; Fatma Aydinoglu; Chiara Ippolito; Cristina Segnani; Nunzia Bernardini; Stefano Taddei; Corrado Blandizzi; Agostino Virdis
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

2.  The effects of cyclooxygenase and nitric oxide synthase inhibition on oxidative stress in isolated rat heart.

Authors:  Nevena Barudzic; Drenka Turjacanin-Pantelic; Vladimir Zivkovic; Dragica Selakovic; Ivan Srejovic; Jovana Joksimovic; Jovana Jakovljevic; Dragan M Djuric; Vladimir Lj Jakovljevic
Journal:  Mol Cell Biochem       Date:  2013-06-09       Impact factor: 3.396

Review 3.  Cardiovascular risk, hypertension, and NSAIDs.

Authors:  William B White
Journal:  Curr Rheumatol Rep       Date:  2007-04       Impact factor: 4.592

4.  Plasma levels of nitrites, PGF1alpha, and nitrotyrosine in LPS-treated rats: functional and histochemical implications in aorta.

Authors:  O H Oztürk; A Cetin; S S Ozdem; N Uysal; U A Kayişli; U K Sentürk; A Yeşilkaya
Journal:  J Physiol Biochem       Date:  2006-03       Impact factor: 4.158

Review 5.  Impact of Oxidative Stress on the Heart and Vasculature: Part 2 of a 3-Part Series.

Authors:  Thomas Münzel; Giovanni G Camici; Christoph Maack; Nicole R Bonetti; Valentin Fuster; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2017-07-11       Impact factor: 24.094

6.  Cyclooxygenase 2 inhibition suppresses tubuloglomerular feedback: roles of thromboxane receptors and nitric oxide.

Authors:  Magali Araujo; William J Welch
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

7.  Impaired Ca(2+) Homeostasis and Decreased Orai1 Expression Modulates Arterial Hyporeactivity to Vasoconstrictors During Endotoxemia.

Authors:  Arthur Oliveira Nonato; Vania C Olivon; Vanessa Dela Justina; Camila Z Zanotto; R Clinton Webb; Rita C Tostes; Victor V Lima; Fernanda R Giachini
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

8.  Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat.

Authors:  Zo Rakotoniaina; Pascal Guerard; Frédéric Lirussi; Luc Rochette; Monique Dumas; Françoise Goirand; Marc Bardou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-10       Impact factor: 3.000

Review 9.  Reactive oxygen species: players in the cardiovascular effects of testosterone.

Authors:  Rita C Tostes; Fernando S Carneiro; Maria Helena C Carvalho; Jane F Reckelhoff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-11-04       Impact factor: 3.619

Review 10.  Nitrative and oxidative stress in toxicology and disease.

Authors:  Ruth A Roberts; Debra L Laskin; Charles V Smith; Fredika M Robertson; Erin M G Allen; Jonathan A Doorn; William Slikker
Journal:  Toxicol Sci       Date:  2009-08-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.